• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    Q BioMed Inks Strontium89 Supply Pact

    PCI Pharma Services Appoints SVP, CFO
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Completes OXGENE Acquisition

    Celonic Group Announces Plans for New Facility in Switzerland

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    WuXi AppTec Completes OXGENE Acquisition

    Live Webinar - Formulation Strategies for Poorly Soluble Molecules

    Celonic Group Announces Plans for New Facility in Switzerland
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Cytovance Biologics

    Syngene

    Federal Equipment Company

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Reed-Lane

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Improving Packaging Processes to Meet Regulatory and Patient Needs

    The rise of advanced automation and packaging technologies

    Improving Packaging Processes to Meet Regulatory and Patient Needs
    Related CONTENT
    • Mogene
    • Orion Corporation
    • Vetio Animal Health
    • Interphex Exhibitor List
    • DCAT Week '17 Q&A: API Market Trends
    06.02.16
    As the global pharmaceuticals market finds itself in an ever-widening spotlight, pharmaceutical and biopharmaceutical companies alike are feeling the pressure to deliver safer, more effective drugs affordably in less time and at lower cost than ever before. In response to these demands, manufacturers are looking for ways to not only speed development and approval but to also enhance manufacturing processes that might not have kept pace with innovations in other industries or in the areas of clinical research and trials.

    Though technology and research have greatly improved the development process and contract research organization (CRO) and contract development manufacturing organization (CDMO) partners are proving valuable to speed development and production, there is little the industry itself can do to decrease approval times; that means manufacturing improvements and innovations that maintain or improve quality will be crucial to decreasing time to market and remaining competitive while meeting new regulations.

    With the continued growth of emerging markets and a rapidly expanding middle class with greater access to treatment and medication options, the global demand for pharmaceuticals continues to grow with the demands and regulations placed on manufacturers following suit. By 2020, global access to medications will be higher than ever, with patients receiving an estimated 4.5 trillion doses, an increase of 24% from 2015.1 With that, spending growth—predicted to increase by 29-32% to $1.4 trillion by 2020, slightly slower than the 35.4% increase from the previous five years—will also continue but is expected to be checked in part by an estimated $90 billion in price reductions, further highlighting the importance of process improvements in manufacturing that could allow for these price reductions without significant profit loses.1

    Poised to make great strides
    Though packaging, especially secondary packaging, may in the past have been more of an afterthought than a priority, contract services providers have positioned themselves as innovators in this space and are making great strides advancing packaging processes, specifically integrating packaging automation technology that can help companies manage production costs and ultimately, drug pricing.

    CDMOs are actively being engaged by pharmaceutical and biopharmaceutical manufacturers for every phase of development; however, outsourcing for packaging specifically is also significant on its own.2 The 2015 Nice Insight Pharmaceutical and Biotechnology Outsourcing Survey found that respondents believed labeling and packaging processes would benefit from technological innovation while 40% of respondents were interested in partnering with a CRO/CDMO that is using technological innovations.3
    One year later, The 2016 Nice Insight CDMO Outsourcing Survey revealed that commercial-scale and clinical scale primary packaging services were outsourced by over half of all respondents while labeling and packaging design/development services were outsourced to 48% and 45% of respondents, respectively.2 These numbers become even more pronounced in certain categories with, for example, 78% of emerging pharma/biotech respondents outsourcing clinical scale primary packaging.2

    To meet evolving packaging needs, manufacturers find themselves faced with the decision to either expand facilities and operations by increasing resources and upgrading/purchasing equipment or outsource packaging to a CDMO that may already have the necessary expertise and facility arrangements. For many companies, preparing to keep pace with demands, meet all upcoming sterilization and labeling requirements, react to requests from within the retail and healthcare industries and maintain aseptic processing needs can be daunting.4 The cost of upgrades, space limitations in established facilities, and the need to hire and train additional staff is often perceived as a potential barrier that makes CDMO engagement appealing.

    Though CDMOs may also face similar challenges in the changing global market, these organizations may be better positioned to adapt and respond to these needs, allowing pharmaceutical/biopharmaceutical companies to focus on drug innovations rather than packaging logistics. Additionally, advancements in packaging to accommodate single doses and the unique needs of biopharmaceuticals have already encouraged many CDMOs to remain at the forefront of changes in this space. With 75% of survey respondents expecting outsourcing expenditures as a whole to rise over the next five years it’s likely that packaging outsourcing will account for some of that increase as regulations continue to develop and manufacturers prepare for the requirements under the Drug Supply Chain Security Act (DSCSA) to gradually take full effect.2

    The potential of automation and emerging technologies
    The use of automation equipment for both primary and secondary packaging can help manufactures save time, simplify or eliminate training, ensure aseptic manufacturing throughout the entire process, and minimize errors. In the 2015 Nice Insight Equipment Survey, 54% of respondents reported spending $100 million or more annually on equipment with 86% of respondents using packaging equipment and services and 80% using automation equipment and services.5 In an effort to encourage and support the adoption of emerging manufacturing technologies, including packaging and labeling operations, by pharmaceutical manufacturers, the Center for Drug Evaluation and Research (CDER) is developing a program supported by the Emerging Technology Team (ETT), a special team comprised of members from various offices including the Office of Pharmaceutical Quality.6,7 This program is intended to help decrease the risk assumed by pharmaceutical companies looking to adopt new technologies by allowing them to submit proposals regarding the use of specific equipment.6

    With 65% of drug shortages caused by manufacturing and quality issues, implementing emerging technology and modernizing pharmaceutical manufacturing can assure drug supply and improve patient safety.7 More specifically, some automation experts believe that robotics may become critical for manufacturers looking to reduce costs and guarantee consistent quality.4 Manufacturers may be hesitant to pursue emerging technology due to perceived high costs and the assumption of complex operations or programing requirements. They may also face more broader concerns regarding delayed approvals because regulators aren’t familiar with new technologies and are unsure how and if they fit into new and existing regulations.4,6 Under the CDER’s new program, the ETT will work with pharmaceutical manufacturers on the submission of their proposals while also helping to identify and facilitate the regulatory review of new manufacturing technology, serving as the lead or co-lead during quality assessments.6

    Yes, robots
    Despite concerns, robotic systems—typically having four or more axes of motion—can be especially useful for packaging due to their flexibility and efficiency, but pharmaceutical manufacturers need to fully understand their sterility requirements with a specific focus on the effecter, or the robot’s gripping mechanism.4 Once in place, these systems can accomplish successive tasks for both primary and secondary packaging (blister packs, boxing, pallet loading, etc.) while also handling multiple packaging configurations on one line (e.g., 60-count and 300-count containers).4 This flexibility is increasingly important as some larger retail outlets demand different packaging with smaller counts to reduce handling errors within pharmacies.4 Fortunately, with robotic systems these changes are often as easy as simply reprogramming rather than adding staff or modifying training, offering a manufacturing cost savings. To further simplify the process, many systems are able to connect to larger IOT networks, allowing for easy access to programing tutorials and streamlined system programming in multiple locations.

    Multi-purpose packaging challenges
    Primary packaging must maintain product purity, help ensure the sterility of every dose and deliver each dose in a way that’s convenient for both patients and caregivers. Secondary packaging must be shippable, easy to handle and stock and, in the case of OTC medications, stand out on retail shelves. Achieving a balance between the two can be challenging. Accurate labeling, properly measured doses, and easy-to-handle packaging are patient-centric solutions that the industry is already embracing, but traceability requirements that are expanding under the Drug Supply Chain Security Act (DSCSA), Title II of the Drug Quality and Security Act of 2013 (DQSA), are adding an additional layer of patient protection and forcing manufacturers to change and enhance packing processes.8,9

    The current, sustained interest in biologics and the potential surge in biosimilars are already helping fuel packaging advancements. But, improving traceability at the package level will require additional design considerations, production procedures and either staff training or the use of automated/robotic systems to ensure that barcodes can be scanned, matched, and packed properly. By 2023, 10 years after the DQSA was signed into law, verification of drug legitimacy, detection and notification of illegitimate products, and the facilitation of product recalls as necessary will all be possible at the package level.9 These requirements are designed to protect patients from unsafe products while protecting manufacturers from illegitimate competition and allowing them to easily notify necessary agencies if issues arise.

    All upcoming regulations are intended to improve quality and safety in the market and therefore it will become increasingly critical for manufactures to ensure that all processes, down to sealing and packing the last box or container are as efficient and effective as possible. As robotics continue to improve, the technology will offer round-the-clock manufacturing options, packaging flexibility and more advanced capabilities than ever before, allowing pharmaceutical companies to improve in-house capabilities while CDMOs can further enhance their offerings to become even more attractive industry partners. 

    References
    1. Global Medicines Use in 2020: Outlook and Implications, IMS Institute for Healthcare Informatics, November, 2015 http://www.imshealth.com/en/thought-leadership/ims-institute/reports/global-medicines-use-in-2020
    2. The 2016 Nice Insight CDMO Outsourcing Survey. January 2016 http://www.niceinsight.com
    3. The 2015 Nice Insight Pharmaceutical and Biotechnology Outsourcing Survey. January 2015 http://www.niceinsight.com
    4. Rios, M., Greb, E., “Robots: The Next Phase in Pharmaceutical Automation.” pharmatech.com, September, 2009 http://www.pharmtech.com/robots-next-phase-pharmaceutical-automation-0?id=&sk=&date=&pageID=2
    5. The 2015 Nice Insight Equipment Survey. January 2015 http://www.niceinsight.com
    6. “Advancement of Emerging Technology Applications to Modernize the Pharmaceutical Manufacturing Base Guidance for Industry.” U.S. Department of Health and Human Services, December, 2015 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM478821.pdf
    7. Kopcha, M., “Modernizing Pharmaceutical Manufacturing to Improve Drug Quality: Ensuring a Safe and Adequate Supply of Drugs.” FDA Voice, February, 2016 http://blogs.fda.gov/fdavoice/index.php/tag/fdas-emerging-technology-team-ett/
    8. Haehl, K., “Choosing the Optimal Drug Delivery System to Meet Patient Needs.” Pharma’s Almanac, 2015 http://www.niceinsightcdmo.com/articles.aspx?post=2772&title=Choosing+the+Optimal+Drug+Delivery+System+to+Meet+Patient+Needs+
    9. “Drug Supply Chain Security Act (DSCSA): Title II of the Drug Quality and Security Act of 2013.” U.S. Department of Health and Human Services, February, 2016 http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/DrugSupplyChainSecurityAct/

    To learn more about Nice Insight contact Emilie Branch, scientific research manager, at emilie@thatsnice.com or visit www.niceinsight.com.
    Related Searches
    • patients
    • biosimilars
    • training
    • automation
    Suggested For You
    Mogene Mogene
    Orion Corporation Orion Corporation
    Vetio Animal Health Vetio Animal Health
    Interphex Exhibitor List Interphex Exhibitor List
    DCAT Week DCAT Week '17 Q&A: API Market Trends
    Whither Washington? Whither Washington?
    The Future of Oral Solids The Future of Oral Solids
    Oral Solid Dosage Outsourcing: Trends & Challenges Oral Solid Dosage Outsourcing: Trends & Challenges
    Fujifilm Launches Bio CDMO Division Fujifilm Launches Bio CDMO Division
    Navigating the Shifting Landscape of Contract API Manufacturing Navigating the Shifting Landscape of Contract API Manufacturing
    Make the Most of Your Life Make the Most of Your Life
    Collaboration is the Heart of Innovation Collaboration is the Heart of Innovation
    The Search &  Rescue Mission for Data Integrity The Search & Rescue Mission for Data Integrity
    Incorporating QbD into Lyophilization Manufacturing Incorporating QbD into Lyophilization Manufacturing
    2016 Annual Outsourcing Survey 2016 Annual Outsourcing Survey

    Related Features

    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20


    • Drug Delivery
      Wet Wipes Increased Prevalence in Drug Development

      Wet Wipes Increased Prevalence in Drug Development

      A number of factors including patient preference are driving the growth of wet wipes in pharma.
      John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing 10.14.20

    • Biosimilars
      Biosimilar Manufacturing Strategies

      Biosimilar Manufacturing Strategies

      Five steps to competing in a post-patent expiry era.
      George I’ons, Owen Mumford Pharmaceutical Services 09.09.20

    • Drug Delivery
      Not Your Father’s Oral Thin Film

      Not Your Father’s Oral Thin Film

      A look at how oral film drug delivery is evolving.
      Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20


    • Drug Delivery | Regulatory Affairs
      Regulatory Overhaul for Medical Devices

      Regulatory Overhaul for Medical Devices

      Implications for the pharmaceutical industry.
      Elizma Parry, Director, Global Clinical Practice, Maetrics 06.04.20

    • Biosimilars
      The U.S. Biosimilars Market: Shaking the “Laggard” Label

      The U.S. Biosimilars Market: Shaking the “Laggard” Label

      Biosimilar uptake set to reshape the U.S. market
      Katya Svoboda and Bob Swann, ICON 05.05.20

    • Drug Delivery
      CEO Spotlight: Will Downie

      CEO Spotlight: Will Downie

      Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO
      Tim Wright, Editor, Contract Pharma 04.01.20


    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Are Biotech Companies Strong Investments?

      Are Biotech Companies Strong Investments?

      Biotech capital raised via IPO has increased dramatically over the past couple of years.
      Jason Monteleone , CEO, Clinipace 05.07.19


    • Drug Delivery
      Nasal Drug Delivery

      Nasal Drug Delivery

      A look at best practices for testing nasal drug delivery devices
      Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC 01.25.19

    • Biosimilars
      Biosimilar  Market Trends

      Biosimilar Market Trends

      2017 was a record year for biosimilar approvals.
      Fiona Greer and Bruno Speder, SGS 09.11.18

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Haste Makes Waste

      Haste Makes Waste

      When to sprint and when to breathe in the race from lab to clinic.
      Christian Cattaruzza, MilliporeSigma 09.11.18

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    Breaking News
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    • Alimentiv Acquires McDougall Scientific
    • Q BioMed Inks Strontium89 Supply Pact
    • PCI Pharma Services Appoints SVP, CFO
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Probiotic Evidenced to Assist Digestive Recovery from a Complex Surgery
    AHPA Submits Comments to FDA on Proposed Traceability Rule
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    AOC Announces EMEA Price Increase
    Mule-Hide Products Co. Introduces Seal-Fast Liqui-Flash
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NAMSA Acquires American Preclinical Services
    Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Memic Receives FDA Marketing Authorization for Hominis
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Fusion Pharmaceuticals Acquires IPN-1087
    Strata Oncology Unveils Strata PATH Trial
    Alimentiv Acquires McDougall Scientific
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    IT Cosmetics Supports Women’s Confidence
    Inter Parfums Reports a Strong Fourth Quarter
    Universal Engraving Announces New President
    Happi

    Latest Breaking News From Happi

    Croda International Acquires Alban Muller
    Givaudan Active Beauty Launches Omegablue
    Sozio Acquires Scentessence
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Abbott Label installs Domino K600i dual bar digital UV inkjet printer
    Crossmark turns to Eagle Systems for cold foil
    Maxcess launches Tidland PressureMax Airshaft Pressure Monitoring System
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Domtar Completes Sale of Personal Care Business
    Mitsui to Sell Chinese Nonwovens Business
    Dr. J's Disinfectant Wipes Approved for Distribution in CA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    FDA OKs Q-Collar Device to Protect Athletes’ Brains During Head Impacts
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login